within Pharmacolibrary.Drugs.ATC.C;

model C07AB04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.4,
    Cl             = 190 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 400 / 1000000,
    adminCount     = 1,
    Vd             = 0.0025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.009666666666666665,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Acebutolol is a selective beta-1 adrenergic receptor blocker (beta-blocker) used in the treatment of hypertension, angina pectoris, and cardiac arrhythmias. It is approved for use in many countries and is currently utilized for its cardioselective properties, especially in patients with concomitant respiratory disease due to its lower risk of bronchospasm.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after single oral dose.</p><h4>References</h4><ol><li><p>Collins, RF (1975). [Pharmacokinetics of acebutolol]. <i>La Nouvelle presse medicale</i> 4(46 Suppl) 3223–3228. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/768905/&quot;>https://pubmed.ncbi.nlm.nih.gov/768905</a></p></li><li><p>Gulaid, AA, et al., &amp; Thomas, RJ (1981). The pharmacokinetics of acebutolol in man, following the oral administration of acebutolol HCl as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d.). <i>Biopharmaceutics &amp; drug disposition</i> 2(2) 103–114. DOI:<a href=&quot;https://doi.org/10.1002/bdd.2510020202&quot;>10.1002/bdd.2510020202</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7248475/&quot;>https://pubmed.ncbi.nlm.nih.gov/7248475</a></p></li><li><p>Choi, JS, &amp; Burm, JP (2002). Pharmacokinetics of acebutolol and its main metabolite, diacetolol after oral administration of acebutolol in rabbits with carbon tetrachloride-induced hepatic failure. <i>Archives of pharmacal research</i> 25(4) 541–545. DOI:<a href=&quot;https://doi.org/10.1007/BF02976615&quot;>10.1007/BF02976615</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12214869/&quot;>https://pubmed.ncbi.nlm.nih.gov/12214869</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C07AB04;
